4910627 said its normalized net income for the first quarter was 39 cents per share, compared with the S&P Capital IQ consensus estimate of 33 cents per share.
EPS fell 10.9% year over year from 44 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $4.7 million, a decline of 12.9% from $5.4 million in the year-earlier period.
The normalized profit margin declined to 6.5% from 7.4% in the year-earlier period.
otal revenue declined on an annual basis to $72.3 million from $73.4 million, and total operating expenses came to $64.9 Medifast Inc.